ArticleFrontiers in oncology2026
Progressive multifocal leukoencephalopathy as the initial manifestation of relapsed lymphoma: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathogens of the human central nervous system-the major viral pathogens.Journal of neurovirology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system (CNS) caused by the reactivation of the JC polyomavirus (JCPyV). While PML is a known complication of hematological malignancies, it is exceedingly rare for it to manifest as the initial neurological symptom of a relapsed lymphoma, occurring even before the start of new systemic chemotherapy. We present a case of a 22-year-old male with a history of lymphoma who presented with progressive neurological deficits. The patient's symptoms, including right-sided hemiparesis and aphasia, were initially mistaken for a CNS lymphoma relapse. Subsequent chemotherapy led to a rapid and severe clinical deterioration. Cerebrospinal fluid testing detected a high viral load of JCPyV. The patient underwent a brain biopsy, which revealed inflammatory changes consistent with the pathological changes of PML. This case highlights a critical diagnostic challenge and underscores the need for a high index of suspicion for PML in any immunocompromised patient with new-onset neurological symptoms, regardless of whether they have commenced new immunosuppressive therapy. It also serves as a poignant reminder of the potential for chemotherapy to exacerbate an underlying viral pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.